Management raised fiscal 2025 EPS guidance to $7.85-$8, a $0.10 increase at the midpoint, reflecting strong Pharma performance and contributions from recent acquisitions. The company expects Q3 to be ...
Cardinal Health prepares to enter direct patient care for the first time after breaking records in 2024 for sales and stock price. Cardinal Health Inc. prepares to enter direct patient care for ...